Regulation of the expression of adoptive tumor rejection immunity by recipient cyclophosphamide-sensitive cells.
Peritoneal exudate T-cells from rats immune to 13762A rat mammary tumor conferred specific tumor rejection immunity on normal recipients. The efficiency of systemic adoptive transfer of tumor rejection immunity with immune peritoneal exudate T-cells was improved by cyclophosphamide (CY) pretreatment of recipients. Optimal potentiation was obtained with a dose of 50 or 100 mg CY per kg body weight given the day before transfer. CY pretreatment of recipients was effective 1 to 3 days prior to transfer. The CY-potentiating effect was lost with longer intervals between CY administration and transfer, indicating recipient recovery. CY pretreatment enabled recipients to reject greater numbers (100 times) of tumor cells and inhibited tumor challenge established before systemic adoptive transfer. The CY-induced potentiation of systemic transfer of tumor immunity was reversed by i.v.-administered normal spleen. We concluded that CY-sensitive host regulatory cells restricted the expression of adoptive tumor rejection immunity. Control of the activity of these regulatory cells allows increased efficacy of effector T-lymphocytes in this system.
D000818:Animals; D003520:Cyclophosphamide / Q000494:pharmacology*; D006084:Graft Rejection; D007112:Immunity, Maternally-Acquired; D007167:Immunotherapy; D008325:Mammary Neoplasms, Experimental / Q000276:immunology* / Q000628:therapy; D009163:Mycobacterium bovis / Q000276:immunology; D009368:Neoplasm Transplantation; D011425:Propionibacterium acnes / Q000276:immunology; D051381:Rats; D011916:Rats, Inbred F344
D003520:Cyclophosphamide